An inverse association between history of childhood eczema and subsequent risk of type 1 diabetes that is not likely to be explained by HLA-DQ, PTPN22, or CTLA4 polymorphisms

Pediatric Diabetes

Volumn 11, Issue 6, 2010, Pages 386-393

  Stene, Lars C ^a,b   Rønningen, Kjersti S ^a   Bjørnvold, Marit ^c   Undlien, Dag E ^c   Joner, Geir ^b,c,d  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

Atopy; Eczema; Epidemiology; Genetics; Type 1 diabetes

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HLA DQ ANTIGEN; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE NON RECEPTOR 22; UNCLASSIFIED DRUG;

ARTICLE; ATOPY; CASE CONTROL STUDY; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ECZEMA; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 77956100434     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2009.00605.x     Document Type: Article

References (44)

1. Asher MI, Montefort S, Björkstén B. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006, 368:733-743.
2. Atkinson MA, Eisenbarth GS. type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 2001, 358:221-229.
3. Bieber T. Atopic dermatitis. N Engl J Med 2008, 358:1483-1494.
4. Olesen AB, Juul S, Birkebaek N, Thestrup-pedersen K. Association between atopic dermatitis and insulin-dependent diabetes mellitus: a case-control study. Lancet 2001, 357:1749-1752.
5. Cardwell CR, Shields MD, Carson DJ, Patterson CC. A meta-analysis of the association between childhood type 1 diabetes and atopic disease. Diabetes Care 2003, 26:2568-2574.
6. Rabin RL, Levinson AI. The nexus between atopic disease and autoimmunity: a review of the epidemiological and mechanistic literature. Clin Exp Immunol 2008, 153:19-30.
7. Stene LC, Joner G. Atopic disorders and risk of childhood-onset type 1 diabetes in individuals. Clin Exp Allergy 2004, 34:201-206. The Norwegian Childhood Diabetes Study Group
8. Tirosh A, Mandel D, Mimouni FB, Zimlichman E, Shochat T, Kochba I. Autoimmune diseases in asthma. Ann Intern Med 2006, 144:877-883.
9. Undlien DE, Lie BA, Thorsby E. HLA complex genes in type 1 diabetes and other autoimmune diseases. Which genes are involved? Trends Genet 2001, 17:93-100.
10. Todd JA, Walker NM, Cooper JD. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 2007, 39:857-864.
11. Bottini N, vang T, cucca F, mustelin T. Role of PTPN22 in type 1 diabetes and other autoimmune diseases. Semin Immunol 2006, 18:207-213.
12. Ueda H, Howson JM, Esposito L. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003, 423:506-511.
13. Morar N, Willis-owen SA, Moffatt MF, Cookson WO. The genetics of atopic dermatitis. J Allergy Clin Immunol 2006, 118:24-34.
14. Palmer CN, Irvine AD, terron-kwiatkowski A. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006, 38:441-446.
15. Baurecht H, Irvine AD, Novak N. Toward a major risk factor for atopic eczema: meta-analysis of filaggrin polymorphism data. J Allergy Clin Immunol 2007, 120:1406-1412.
16. Jones EY, Fugger L, Strominger JL, Siebold C. MHC class II proteins and disease: a structural perspective. Nat Rev Immunol 2006, 6:271-282.
17. Teft WA, Kirchhof MG, Madrenas J. A molecular perspective of CTLA-4 function. Annu Rev Immunol 2006, 24:65-97.
18. Mustelin T, Vang T, Bottini N. Protein tyrosine phosphatases and the immune response. Nat Rev Immunol 2005, 5:43-57.
19. Munthe-kaas MC, Carlsen KL, Carlsen KH. HLA Dr-Dq haplotypes and the TNFA-308 polymorphism: associations with asthma and allergy. Allergy 2007, 62:991-998.
20. Ober C, Hoffjan S. Asthma genetics 2006 the long and winding road to gene discovery. Genes Immun 2006, 7:95-100.
21. Cookson W. The alliance of genes and environment in asthma and allergy. Nature 1999, 402(Suppl):B5-B11.
22. Krain LS, Terasaki PI. HL-A types in atopic dermatitis. Lancet 1973, 1:1059-1060.
23. Schultz larsen F. Genetic epidemiology of atopic dermatitis. Atopic Dermatitis: The Epidemiology, Causes and Prevention of Atopic Eczema 2000, 113-124. Williams HC. In:, ed., Cambridge, Cambridge University Press
24. Horton R, Wilming L, Rand V. Gene map of the extended human MHC. Nat Rev Genet 2004, 5:889-899.
25. Maier LM, Twells RC, Howson JM. Testing the possible negative association of type 1 diabetes and atopic disease by analysis of the interleukin 4 receptor gene. Genes Immun 2003, 4:469-475.
26. Munthe-kaas MC, Carlsen KH, Helms PJ. CTLA-4 polymorphisms in allergy and asthma and the TH1/ TH2 paradigm. J Allergy Clin Immunol 2004, 114:280-287.
27. Maier LM, Howson JM, Walker N. Association of IL13 with total IgE: evidence against an inverse association of atopy and diabetes. J Allergy Clin Immunol 2006, 117:1306-1313.
28. Stene LC, Nafstad P. Relation between occurrence of type 1 diabetes and asthma. Lancet 2001, 357:607-608.
29. Bjørnvold M, Undlien DE, Joner G. Joint effects of HLA, INS, PTPN22 and CTLA4 genes on the risk of type 1 diabetes. Diabetologia 2008, 51:589-596.
30. Nafstad P, Magnus P, Gaarder PI, Jaakkola JJ. Exposure to pets and atopy-related diseases in the first 4 years of life. Allergy 2001, 56:307-312.
31. Greenland S, Maldonado G. Inference on collapsibility in generalized linear-models. Biom J 1994, 36:771-782.
32. Williams HC. What is atopic dermatitis and how should it be defined in epidemiological studies? Atopic dermatitis: The epidemiology, causes and prevention of atopic eczema 2000, 3-24. Williams HC. In:, ed., Cambridge, Cambridge University Press
33. Williams HC. Atopic Dermatitis: The Epidemiology, Causes and Prevention of Atopic Eczema 2000, Cambridge, Cambridge University Press
34. Øien T, Storrø O, Johnsen R. Assessing atopic disease in children two to six years old: reliability of a revised questionnaire. Prim Care Resp J 2008, 17:164-168.
35. Hoenig JM, Heisey DM. The abuse of power: The pervasive fallacy of power calculations for data analysis. Am Stat 2001, 55:19-24.
36. Jones G, Wu S, Jang N, Fulcher D, Hogan P, Stewart G. Polymorphisms within the CTLA4 gene are associated with infant atopic dermatitis. Br J Dermatol 2006, 154:467-471.
37. Heinzmann A, Plesnar C, Kuehr J, Forster J, Deichmann KA. Common polymorphisms in the CTLA-4 and CD28 genes at 2q33 are not associated with asthma or atopy. Eur J Immunogenet 2000, 27:57-61.
38. Jasek M, Luszczek W, Obojski A. Distribution of CTLA-4 polymorphisms in allergic asthma. Int Arch Allergy Immunol 2006, 141:223-229.
39. Majorczyk E, Jasek M, Ploski R. Association of PTPN22 single nucleotide polymorphism with rheumatoid arthritis but not with allergic asthma. Eur J Hum Genet 2007, 15:1043-1048.
40. Huang SK, Zwollo P, Marsh DG. Class II major histocompatibility complex restriction of human T cell responses to short ragweed allergen, Amb a V. Eur J Immunol 1991, 21:1469-1473.
41. Saeki H, Kuwata S, Nakagawa H. Analysis of disease-associated amino acid epitopes on HLA class II molecules in atopic dermatitis. J Allergy Clin Immunol 1995, 96:1061-1068.
42. Lee HJ, Ha SJ, Han H, Kim JW. Distribution of HLA-A, B alleles and polymorphisms of TAP and LMP genes in Korean patients with atopic dermatitis. Clin Exp Allergy 2001, 31:1867-1874.
43. Decreased prevalence of atopic diseases in children with diabetes. J Pediatr 2000, 137:470-474. Eurodiab Substudy 2 Study Group
44. Murphy K, Travers P, Walport M. Janeway's Immunobiology 2008, 7 ed., New York, Garland Sciences